| Authors: |
Annesley C; Seattle Children's Therapeutics, Seattle Childrens Hospital, Seattle, WA.; Department of Pediatrics, University of Washington, Seattle, WA., Seidel K; Seattle Children's Therapeutics, Seattle Childrens Hospital, Seattle, WA., Wu Q; Clinical Biostatistics, Fred Hutchinson Cancer Center, Seattle, WA., Summers C; Seattle Children's Therapeutics, Seattle Childrens Hospital, Seattle, WA.; Department of Pediatrics, University of Washington, Seattle, WA., Wayne AS; Department of Pediatrics, Children's Hospital of Los Angeles, University of Southern California, Los Angeles, CA., Pulsipher MA; Division of Pediatric Hematology and Oncology, Intermountain Primary Children's Hospital, Huntsman Cancer Institute, Spencer Fox Eccles School of Medicine at the University of Utah, Salt Lake City, UT., Agrawal AK; Division of Oncology, University of California San Francisco Benioff Children's Hospitals, Oakland, CA., Brown CT; Seattle Children's Therapeutics, Seattle Childrens Hospital, Seattle, WA., Mgebroff S; Seattle Children's Therapeutics, Seattle Childrens Hospital, Seattle, WA., Lindgren C; Seattle Children's Therapeutics, Seattle Childrens Hospital, Seattle, WA., Rawlings-Rhea S; Seattle Children's Therapeutics, Seattle Childrens Hospital, Seattle, WA., Huang W; Seattle Children's Therapeutics, Seattle Childrens Hospital, Seattle, WA., Wilson AL; Seattle Children's Therapeutics, Seattle Childrens Hospital, Seattle, WA., Jensen MC; Seattle Children's Therapeutics, Seattle Childrens Hospital, Seattle, WA., Park JR; Seattle Children's Therapeutics, Seattle Childrens Hospital, Seattle, WA.; Department of Pediatrics, University of Washington, Seattle, WA.; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN., Gardner RA; Seattle Children's Therapeutics, Seattle Childrens Hospital, Seattle, WA.; Department of Pediatrics, University of Washington, Seattle, WA.; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN. |
